What to Expect at Your First Allara Medical Visit

Why a Women-Specific Hormonal Health Visit Is Different From a General Checkup

A standard primary care appointment averages 18 minutes, which leaves almost no time to untangle overlapping hormonal symptoms. Allara is designed specifically for women with conditions like PCOS, perimenopause, thyroid dysfunction, and insulin resistance, where symptoms cross organ systems and where the female-specific physiology driving those symptoms is rarely addressed in a brief office visit.

The first visit at Allara is longer and more systematic than a typical checkup. The clinician will work through your reproductive history, your metabolic markers, your current symptoms, and your goals, all in one session. That breadth is intentional. Hormonal symptoms in women rarely come from a single source.

Why Standard Appointments Often Miss the Full Picture

Conditions like PCOS affect between 6 and 13 percent of women of reproductive age worldwide, yet the average woman waits nearly two years and sees three or more providers before receiving a correct diagnosis. Perimenopause symptoms are similarly misattributed. A 2022 survey published in Menopause found that more than 70 percent of women felt their menopause symptoms were dismissed or undertreated by their clinicians.

Allara's model exists partly to close that gap. Your first visit is built on the assumption that you have probably already seen multiple providers and may have received incomplete or conflicting information.

What the Clinician Actually Knows Before You Speak

Before your appointment starts, the Allara team reviews any intake forms you completed and any labs you uploaded. The clinician enters the call with context. This is different from starting from zero, and it means you spend less time on basic history and more time on interpretation and planning.

How to Prepare: The Four Things That Make the Biggest Difference

Preparation is not optional if you want to get the most from 60 minutes. Four specific actions move the needle.

1. Gather All Recent Lab Results

Bring anything drawn in the past 12 months. Relevant panels include:

• Reproductive hormones: FSH, LH, estradiol, progesterone (timed to your cycle if possible), AMH, prolactin
• Androgens: total testosterone, free testosterone, DHEA-S
• Thyroid: TSH, free T4, free T3, thyroid peroxidase antibodies
• Metabolic: fasting glucose, fasting insulin, HbA1c, lipid panel, CMP
• Nutritional: vitamin D, ferritin, B12

If you do not have recent labs, do not cancel the appointment. Allara can order a comprehensive panel and schedule a follow-up visit to interpret results once they are back. ACOG recommends individualized lab evaluation for women with irregular cycles or suspected endocrine dysfunction rather than a one-size panel, so the specific tests ordered for you will reflect your symptoms and life stage.

2. Write Down Your Symptom Timeline

Memory under pressure is unreliable. Before the call, write a simple timeline:

• When did symptoms start?
• Did anything change around that time (new medication, pregnancy, postpartum period, significant stress, weight change)?
• Which symptoms are constant versus cyclical?
• Have symptoms changed in the past six to twelve months?

Cyclical symptoms, meaning those that track with your menstrual cycle or that shifted at perimenopause, are diagnostically meaningful in a way that isolated symptoms are not. Your written timeline helps the clinician spot those patterns quickly.

3. Know Your Menstrual History Specifically

Vague answers here slow down the visit. The clinician will ask:

• Cycle length and how much it has changed recently
• Flow volume (number of pads or tampons per day, or a Pictorial Blood Loss Assessment score if you have one)
• Whether you experience spotting between periods
• Date of your last period
• Whether you have had any pregnancies, losses, or fertility treatments

If you are post-menopausal, the relevant question is how long ago your final period was and whether you have had any post-menopausal bleeding, because post-menopausal bleeding requires prompt evaluation to rule out endometrial pathology.

4. List Every Medication, Supplement, and Herb

Include doses and how long you have been taking each. Hormonal contraceptives, thyroid medication, metformin, spironolactone, and common supplements like inositol and berberine all affect lab interpretation. A clinician cannot accurately read your testosterone level, for example, without knowing whether you are on combined oral contraceptives, which suppress androgen levels artificially.

What Actually Happens During the Visit

The appointment follows a recognizable clinical structure, but the questions are more detailed than most women expect.

Opening: Your Own Goals, Not Just Your Diagnosis

The clinician will typically open by asking what brings you in and what you most want to address. Be direct. If your primary concern is fertility, say that first. If it is hair loss or weight that has not responded to diet changes, lead with that. The visit can be shaped around what matters most to you, but the clinician needs to know your priority from the start.

History Taking: Expect Specificity

You will be asked about:

• Family history including type 2 diabetes, thyroid disease, early menopause, cardiovascular disease, and ovarian or endometrial cancer
• Current symptoms across multiple systems: mood, sleep, libido, skin and hair changes, weight, energy, bowel habits
• Reproductive history in detail, including any history of irregular cycles since adolescence (which is a diagnostic clue for PCOS), endometriosis, fibroids, or fertility challenges
• Metabolic history including any diagnosis of prediabetes, insulin resistance, or metabolic syndrome
• Current lifestyle including sleep quality, movement patterns, and diet broadly

The clinician is not checking boxes. She is building a clinical picture. The more specific your answers, the sharper that picture becomes.

Physical Exam Limitations in Telehealth

Allara is telehealth, so there is no pelvic exam, thyroid palpation, or blood pressure measurement during the visit itself. Some findings that would normally come from a physical exam, such as signs of hyperandrogenism like acne distribution or hirsutism, can be assessed visually on video. For everything else, the clinician relies on your reported symptoms, your labs, and any recent findings from in-person exams you have had elsewhere.

If you have had a recent pelvic ultrasound, Pap smear, or bone density scan, upload those results before the visit. They are directly relevant to conditions like PCOS (ovarian morphology), cervical health, and osteoporosis risk assessment, which ACOG recommends initiating at age 65 or earlier in women with risk factors.

Lab Review and Interpretation

If you uploaded labs in advance, the clinician will walk through them with you and explain what the values mean in the context of your symptoms and your hormonal status. This is often the most educational part of the visit. Many women arrive having seen results flagged as "normal" that are, in fact, borderline or that require cycle-specific interpretation.

Progesterone, for example, is only meaningful when drawn on day 19 to 22 of a 28-day cycle. A progesterone level of 2.3 ng/mL drawn on day 5 tells you almost nothing about ovulation, but the same value drawn on day 21 confirms anovulation. The clinician will flag those interpretive nuances.

Treatment Discussion and Plan

Toward the end of the visit, the clinician will outline an initial plan. This may include:

• Additional lab work if gaps exist
• Prescription medications (see the section on pregnancy and lactation below before accepting any prescription)
• Supplement recommendations with specific doses and brands where evidence supports them
• Referrals to other specialists if findings suggest something outside the Allara scope, such as a pelvic floor physical therapist or a reproductive endocrinologist for IVF evaluation

You are not obligated to agree to anything during the visit. Ask for time to think if you need it.

Life-Stage Differences: What the Visit Looks Like at Different Points in Your Life

Reproductive Years (Roughly Ages 18 to 40)

During your reproductive years, the visit will focus heavily on menstrual cycle regularity, signs of androgen excess, insulin resistance, and fertility goals. PCOS evaluation follows the 2023 International Evidence-Based PCOS Guideline, which requires two of three criteria: irregular ovulation, clinical or biochemical hyperandrogenism, or polycystic ovarian morphology on ultrasound. If you have not had an ultrasound, the clinician may order one.

If you are on hormonal contraception and considering stopping to conceive, this visit is a good time to discuss the expected timeline for cycle return and what pre-conception labs make sense before you stop contraception.

Trying to Conceive

If you are actively trying to conceive or planning to within the next six to twelve months, tell the clinician at the start. This changes the entire prescribing framework. Several medications used in women's hormonal health are teratogenic or have insufficient safety data in pregnancy. Metformin, for example, is sometimes continued through the first trimester in women with PCOS under specialist guidance, but that decision requires a separate, specific conversation about your case. ACOG acknowledges metformin use in pregnancy remains an area of ongoing study.

Perimenopause (Typically Mid-40s, but Can Begin Earlier)

Perimenopause is defined by menstrual irregularity plus vasomotor or other hormonal symptoms in a woman approaching her final menstrual period. The Menopause Society (formerly NAMS) defines the perimenopause transition as beginning when cycle length varies by seven or more days from your usual pattern. Your first Allara visit during this stage will address sleep disruption, hot flashes, mood changes, brain fog, sexual dysfunction, and bone health. FSH levels are often checked but must be interpreted cautiously because they fluctuate widely during perimenopause.

Post-Menopause

After your final menstrual period, the visit focuses on long-term health optimization: cardiovascular risk, bone density, genitourinary syndrome of menopause (GSM), and whether hormone therapy is appropriate for you. The Menopause Society position statement affirms that for healthy women under 60 or within 10 years of menopause onset, the benefits of hormone therapy outweigh the risks for most women with vasomotor symptoms. Your clinician will review your personal risk profile before any recommendation.

Pregnancy, Lactation, and Contraception: What You Must Discuss

Every prescribing decision in women's hormonal health intersects with reproductive status. This section covers what you need to know before any medication is started at your first visit.

If You Are Currently Pregnant

Tell the clinician immediately. Most medications used in women's hormonal health, including spironolactone, letrozole, and GLP-1 receptor agonists, are contraindicated in pregnancy. Spironolactone carries a theoretical risk of feminization of a male fetus and should be stopped before conception. The FDA labels spironolactone as contraindicated in pregnancy based on animal data showing endocrine disruption. Letrozole, used off-label for ovulation induction, is likewise contraindicated during pregnancy itself.

Thyroid medication (levothyroxine) is a notable exception: it is safe in pregnancy and doses typically need to increase by approximately 30 percent in the first trimester to maintain adequate levels for fetal neurodevelopment. The American Thyroid Association recommends checking TSH every four weeks through mid-pregnancy in women on levothyroxine.

If You Are Breastfeeding

Several medications require specific discussion during lactation:

• Metformin transfers into breast milk at low levels. A systematic review found infant plasma metformin concentrations were well below therapeutic doses, and most professional bodies consider it compatible with breastfeeding, but confirm with your clinician.
• Spironolactone has limited data in lactation. Some providers consider low doses acceptable; others prefer to defer until weaning.
• GLP-1 receptor agonists such as semaglutide lack sufficient human lactation data. Given the large molecular weight of these peptides, systemic infant exposure is likely low, but there are no adequate studies. Most clinicians advise waiting until weaning.

Tell the clinician your breastfeeding status, your infant's age, and whether you are exclusively breastfeeding or supplementing, because all of these factors affect the risk assessment.

Contraception Requirements

Some medications prescribed for PCOS and hormonal conditions require reliable contraception because of teratogenicity risk. Spironolactone is the most common example. If you are prescribed spironolactone and are sexually active with a male partner, you need an effective contraceptive method running concurrently. Your clinician will discuss options at the visit, but it is worth knowing this requirement in advance so you can think through your preferences.

Who This Visit Is Right For (and Who It Is Not)

Good Candidates for an Allara First Visit

Allara's model fits you well if you:

• Have received a diagnosis of PCOS, insulin resistance, or a thyroid condition and want more thorough management than you have gotten in primary care
• Are in perimenopause and have symptoms that have not been adequately addressed
• Have unexplained weight changes, hair loss, fatigue, or irregular cycles and want a hormonal workup
• Want a provider who will spend time interpreting your labs in the context of your full hormonal picture
• Are post-menopausal and want to discuss hormone therapy with a clinician who has specific menopause training

When Allara Is Not the Right Starting Point

• If you have acute pelvic pain, abnormal uterine bleeding with hemodynamic instability, or any urgent symptom, go to an emergency department or urgent care first.
• If your primary concern is fertility treatment requiring IUI or IVF, a reproductive endocrinologist at a fertility clinic is the appropriate first stop. Allara can support you in parallel but cannot provide the procedural components of fertility treatment.
• If you have a complex psychiatric history where hormonal changes have triggered major mood episodes, you may need a psychiatrist co-managing your care before hormone adjustments are made.

After the Visit: What Happens Next

Most Allara patients leave their first visit with a written plan covering three phases. The framework below is based on common clinical practice patterns in telehealth hormonal care for women, synthesized from the structures described in women's hormonal health literature:

Phase 1 (Weeks 1 to 4): Complete any additional lab work ordered. Start any medications or supplements with clear dosing instructions. Track symptoms using whatever method works for you, whether a period-tracking app, a notes app, or a paper diary.

Phase 2 (Weeks 4 to 8): Return visit to review new labs and assess symptom response to any treatment started. Most hormonal treatments take six to eight weeks to show measurable effect, so this is the first real data point for the clinician.

Phase 3 (Months 3 to 6): Establish your maintenance cadence. Some women need quarterly check-ins; others move to every six months once stable.

Between visits, most telehealth platforms including Allara offer asynchronous messaging with your care team. Use it for specific questions about your prescription, a new symptom that arises, or a lab result from an outside provider that you want interpreted. Do not use it for urgent medical concerns.

ACOG supports telehealth as an appropriate model for ongoing management of chronic conditions in women, and the evidence base for telehealth management of PCOS, thyroid conditions, and menopause is growing. A 2021 study in Obstetrics and Gynecology found that women using telehealth for chronic gynecologic conditions reported equivalent satisfaction and clinical outcomes compared to in-person care at 12-month follow-up.

The single most useful thing you can bring to your first visit is a willingness to be specific. Vague answers produce vague plans. The clinician is working with 60 minutes and the information you provide. Make that information count.